HKEX Review of Disruption Risk to an Applicant's Business Model

Hong Kong Exchanges and Clearing Limited (HKEX) has intensified its scrutiny of disruption risk to an applicant’s business model, a trend that accelerated in the second half of 2024 and continues into 2025. This shift is not a theoretical exercise but a direct response to a series of high-profile listing applications that collapsed or were withdrawn after regulators identified fundamental flaws in their value propositions, often tied to unsustainable competitive advantages or over-reliance on a single technology. The 2024 amendments to the HKEX Listing Rules, particularly the enhanced guidance under Listing Decision HKEX-LD119-2024, explicitly require sponsors to assess and disclose the material risks of technological, regulatory, or market disruption that could render the applicant’s business model obsolete within the foreseeable future. This represents a material escalation from the previous “going concern” standard, which focused on financial viability over a 12-month horizon, to a forward-looking, multi-year assessment of structural risk. For CFOs and company secretaries preparing for a Main Board or GEM listing, the implication is clear: a robust, defensible business model narrative is no longer sufficient; the application must demonstrate how the company will survive and adapt to foreseeable disruptions, supported by quantitative stress-testing and scenario analysis. The HKEX’s stance, echoed in recent SFC enforcement actions against sponsors for inadequate due diligence on business model sustainability, forces applicants to confront the uncomfortable question of whether their business is genuinely resilient or merely a temporary arbitrage of market inefficiencies.

The Regulatory Framework: From Going Concern to Disruption Resilience

The HKEX’s focus on disruption risk is codified within the broader framework of sponsor due diligence obligations under the Listing Rules and the SFC’s Code of Conduct. The shift is not a new rule per se, but a sharpened interpretation of existing requirements, particularly in the context of technology-driven and platform-based businesses.

The Sponsor’s Expanded Due Diligence Obligations

Under paragraph 17 of the SFC’s Code of Conduct for Persons Licensed by or Registered with the Securities and Futures Commission (the “Code of Conduct”), a sponsor must exercise reasonable care and judgment to ensure that the information in a listing document is true, accurate, and complete. The HKEX’s Listing Decision HKEX-LD119-2024, issued in October 2024, explicitly extends this to a forward-looking assessment of business model disruption. The decision requires sponsors to conduct a “disruption risk assessment” that analyses the applicant’s core value proposition, identifies key drivers of competitive advantage, and evaluates the probability and materiality of technological, regulatory, or market changes that could undermine these drivers. The decision cites the example of a ride-hailing platform that relied on regulatory exemptions for gig-economy workers. The sponsor was required to model the financial impact of a scenario where these exemptions were revoked, including a 40% increase in labour costs and a 15% reduction in driver supply, and to disclose the results in the prospectus. This is a direct departure from the historical practice of merely stating that a risk “could” occur, without quantifying its potential impact.

The 12-Month Horizon vs. The Multi-Year Assessment

The traditional “going concern” assessment under HKAS 1 requires management to evaluate an entity’s ability to continue as a going concern for at least 12 months from the end of the reporting period. The HKEX’s disruption risk assessment, however, demands a longer view. In a 2023 consultation paper on listing regime enhancements, the HKEX proposed that sponsors should assess disruption risk over a period of at least three to five years, or the expected life cycle of the core technology, whichever is longer. This was formalised in the 2024 Listing Decision. For example, a biotech applicant developing a novel gene therapy must now assess the risk of a competing CRISPR-based therapy entering the market within the next three years, and model the impact on its revenue projections and valuation. The HKEX has also indicated that it will consider the applicant’s own strategic plans for mitigating disruption, such as diversification into adjacent markets or investment in R&D, but it will not accept generic statements about “continuous innovation” without specific, measurable milestones.

SFC Enforcement as a Backstop

The SFC has demonstrated its willingness to enforce these standards. In its 2024 enforcement report, the SFC highlighted a case where a sponsor was fined HKD 12 million for failing to adequately assess the disruption risk to a fintech applicant’s business model. The applicant, a digital payments platform, claimed a competitive advantage based on its proprietary algorithm for fraud detection. The sponsor accepted this claim at face value, without conducting independent technical due diligence. The SFC found that the algorithm was a standard open-source model, and the applicant’s advantage was entirely dependent on a data-sharing agreement with a single bank, which was subject to renewal every 12 months. The sponsor was sanctioned for failing to identify this concentration risk, which the SFC deemed a material disruption risk. This enforcement action serves as a clear signal that the SFC expects sponsors to go beyond desk research and engage independent technical experts to verify the sustainability of an applicant’s core technology.

Practical Application: Assessing Disruption Risk in Key Sectors

The practical application of the disruption risk assessment varies significantly across sectors. The HKEX has provided sector-specific guidance in its Listing Decisions, focusing on three areas where disruption risk is most acute: technology-driven platforms, biotech and life sciences, and traditional businesses undergoing digital transformation.

Technology-Driven Platforms: The Concentration Trap

For technology-driven platforms, the HKEX’s primary concern is the concentration of competitive advantage in a single, potentially fragile source. The 2024 Listing Decision specifically addresses the risk of “platform dependency,” where an applicant’s business model is entirely reliant on a single technology, data source, or regulatory framework. The decision requires sponsors to identify the “critical dependency” and assess its vulnerability. For example, a social commerce platform that relies on a proprietary recommendation algorithm must demonstrate that the algorithm is not easily replicable by competitors, and that the platform has a plan to migrate to an alternative algorithm if the core technology becomes obsolete. The HKEX has also flagged the risk of “regulatory disruption” for platform businesses that operate in grey areas. A 2023 HKEX guidance note on the listing of virtual asset-related businesses explicitly requires sponsors to assess the risk of a regulatory crackdown on cryptocurrency trading, including the potential for a complete ban in the applicant’s primary market. The assessment must include a quantitative analysis of the impact on revenue, user base, and valuation, and a disclosure of the applicant’s contingency plans, such as pivoting to a different business model or relocating to a more favourable jurisdiction.

Biotech and Life Sciences: The Technology Obsolescence Risk

Biotech applicants face a different set of disruption risks, primarily centred on technology obsolescence and clinical trial failure. The HKEX’s Chapter 18A of the Main Board Listing Rules, which governs the listing of biotech companies without revenue, already requires a detailed analysis of the applicant’s core product pipeline. The 2024 Listing Decision extends this to a forward-looking assessment of competing technologies. The sponsor must identify the leading competing technologies in the applicant’s therapeutic area, assess their stage of development, and model the impact of a competing therapy reaching the market before the applicant’s product. For example, an applicant developing a monoclonal antibody for a specific cancer must assess the risk of a competing CAR-T cell therapy receiving regulatory approval within the next two years, and model the impact on the applicant’s market share and pricing power. The HKEX has also indicated that it will consider the applicant’s intellectual property (IP) portfolio as a mitigating factor, but only if the IP is demonstrably defensible and covers the core technology. A 2024 HKEX study found that 40% of biotech applicants that withdrew their listing applications cited “technology obsolescence risk” as a material factor, up from 25% in 2022.

Traditional Businesses Undergoing Digital Transformation

Traditional businesses, such as retailers or manufacturers, that are undergoing digital transformation face disruption risk from the failure of their transformation initiatives. The HKEX’s focus here is on the “execution risk” of the digital strategy. The sponsor must assess whether the applicant has the necessary technical expertise, financial resources, and organisational capacity to successfully implement its digital transformation plan. The assessment must include a detailed review of the applicant’s IT infrastructure, data management capabilities, and cybersecurity protocols. A 2023 HKEX Listing Decision on a traditional logistics company that claimed to be a “tech-enabled logistics platform” required the sponsor to verify that the company’s digital platform was actually being used by customers and was generating a measurable improvement in operational efficiency. The sponsor found that the platform was only used by 10% of the company’s customers, and the claimed efficiency gains were not statistically significant. The HKEX required the company to remove the “tech-enabled” label from its prospectus and to disclose the actual usage data. This case illustrates the HKEX’s insistence on substance over form when assessing disruption risk for traditional businesses.

Strategic Implications for Applicants and Sponsors

The HKEX’s enhanced focus on disruption risk has significant strategic implications for both applicants and sponsors. The burden of proof has shifted from a passive disclosure of risks to an active demonstration of resilience.

The Need for a “Disruption Resilience” Narrative

Applicants must now develop a “disruption resilience” narrative that goes beyond the traditional business model description. This narrative must answer three key questions: What is the single point of failure in the business model? What is the probability and materiality of that failure? And what is the plan B if the failure occurs? The narrative must be supported by quantitative analysis, including stress-testing of key financial metrics under multiple disruption scenarios. For example, a fintech applicant that relies on a partnership with a single bank for its payment processing must model the impact of the partnership being terminated, including a 50% reduction in transaction volume and a 30% increase in processing costs. The applicant must also disclose its contingency plan, such as migrating to a multi-bank platform or developing its own processing infrastructure. The HKEX has indicated that it will look favourably on applicants that have already taken steps to mitigate disruption risk, such as entering into diversification agreements or investing in R&D.

Sponsors Must Invest in Independent Technical Due Diligence

Sponsors can no longer rely solely on management representations or generic industry reports to assess disruption risk. The SFC’s enforcement actions and the HKEX’s Listing Decisions make it clear that sponsors must engage independent technical experts to verify the sustainability of an applicant’s core technology. This is particularly critical for technology-driven and biotech applicants. The cost of this due diligence is material. A 2024 survey by the Hong Kong Investment Funds Association found that the average cost of independent technical due diligence for a Main Board listing has increased by 35% since 2022, to approximately HKD 2.5 million per engagement. However, the cost of getting it wrong is far higher. The SFC’s maximum fine for sponsor misconduct is HKD 10 million, and the reputational damage can be career-ending. Sponsors must also ensure that their due diligence reports are properly documented and can withstand regulatory scrutiny. The HKEX has indicated that it will request these reports during the vetting process, and any gaps in the analysis will result in a delay or rejection of the application.

The Role of the Company Secretary and Legal Counsel

Company secretaries and legal counsel play a critical role in ensuring that the disruption risk assessment is properly integrated into the listing application. They must work with the sponsor to identify the key disruption risks, develop the resilience narrative, and ensure that the prospectus disclosures are accurate and complete. The company secretary must also ensure that the board of directors has approved the disruption risk assessment and that the board’s minutes reflect its discussion of the key risks and mitigation strategies. The HKEX’s Listing Decision requires the board to take “ownership” of the disruption risk assessment, and the board’s failure to do so can be cited as a deficiency in the application. Legal counsel must also advise on the regulatory implications of the disruption risk assessment, particularly for cross-border applicants. For example, a PRC-based applicant that relies on a VIE structure to circumvent foreign ownership restrictions must assess the risk of a regulatory change that invalidates the VIE structure, and model the impact on the applicant’s ability to continue its operations. This risk is particularly acute in light of the PRC’s 2023 Data Security Law and the 2024 Anti-Espionage Law, which have created significant uncertainty for VIE-structured companies.

Closing Takeaways

1. Integrate a quantitative disruption risk assessment into your listing application from the outset, modelling at least three plausible scenarios (e.g., technology obsolescence, regulatory crackdown, market entry by a well-capitalised competitor) and stress-testing key financial metrics over a three-to-five-year horizon.
2. Engage an independent technical expert to verify the sustainability of your core technology and document their findings in a report that can be shared with the HKEX and the SFC upon request; budget for a cost of approximately HKD 2.5 million for this engagement.
3. Develop a concrete “Plan B” for each identified disruption risk, including specific milestones and a timeline for implementation, and disclose this plan in the prospectus under a dedicated “Business Model Resilience” section.
4. Ensure the board of directors formally approves the disruption risk assessment and that the board’s minutes reflect a substantive discussion of the key risks and mitigation strategies, as the HKEX views board ownership as a critical element of a credible application.
5. For cross-border applicants, particularly those using a VIE structure, explicitly assess the risk of a regulatory change that invalidates the structure and model the financial and operational impact, referencing the PRC’s 2023 Data Security Law and the 2024 Anti-Espionage Law as material risk factors.